Navigation Links
Aton Pharma Introduces Expanded Distribution of Lacrisert(R) (hydroxypropyl cellulose ophthalmic insert) at Hawaiian Eye
Date:1/24/2008

LAWRENCEVILLE, N.J., Jan. 24 /PRNewswire/ -- Aton Pharma, Inc., a global specialty pharmaceutical company, announced today that it has launched an expanded, comprehensive distribution program that incorporates sampling, reimbursement assistance and patient education resources, for the dry eye medication Lacrisert(R) (hydroxypropyl cellulose ophthalmic insert). Lacrisert is a unique preservative-free, once-daily*, sustained release prescription insert that helps to retain moisture, stabilize the tear film, and lubricate the eye.

"As part of Aton's mission to ensure patient access to important therapies, we have established supply chain and commercialization processes to make certain Lacrisert is well-supported and readily available to patients," said Michael G. Wells, Chief Executive Officer of Aton Pharma. "As a company specializing in essential treatments for under-treated diseases, we are proud to provide a therapeutic option for dry eye with a strong history of effectiveness and safety."

"Once the patient inserts Lacrisert in the morning, it usually lasts the entire day, so it's something that is helpful to offer patients suffering from chronic pain from dry eye disease," explained Penny Asbell, M.D., Professor of Ophthalmology at The Mount Sinai School of Medicine and co-author of the pivotal textbook 'Dry Eye Disease, the Clinician's Guide to Diagnosis and Treatment.' "One of the advantages of Lacrisert is that it is preservative- free."

Lacrisert is administered into the inferior cul-de-sac of the eye, where it gently dissolves to provide lubrication and protection to the surface of the eye. In some patients, Lacrisert may also help slow, stop or reverse further damage to the corneal surface.

"Due to the great variety among dry eye patient profiles, practitioners need to be armed with as many effective treatment options as possible," added Dr. Asbell. "Our challenge is to match the patients with the right medications to give
'/>"/>

SOURCE Aton Pharma, Inc.
Copyright©2008 PR Newswire.
All rights reserved

7

GOOD

Page: 1 2 3

Related biology technology :

1. ProMetic announces scale-up of prion removal resin in plasma product for biopharmaceutical use
2. Angiotech Pharmaceuticals, Inc. - Notice of Conference Call and Webcast
3. Wedgewood Pharmacy Will Continue to Provide Avastin(R) to Ophthalmologists and Retinal Specialists
4. ProMetic and MacoPharma announce successful completion of P-Capt(R) prion reduction filter clinical studies
5. Good Neighbor Pharmacy(R) Ironman Competitor Inspires Individuals with Diabetes to Live Without Limits
6. Pharmaxis Aridol Gains First Asian Approval
7. Delaware Court Denies Motion by SIGA Technologies Seeking to Dismiss PharmAthenes Legal Action in Breach of Contract Lawsuit Against SIGA
8. Helix BioPharma Corp. contracts KBI Biopharma to develop an L-DOS47 clinical packaging format
9. WuXi PharmaTech (NYSE: WX) CEO Honored among the 2007 China Top 10 Influential Entrepreneurs
10. VIA Pharmaceuticals Names Rebecca Taub Senior Vice President of Research and Development
11. Beyond DTC: Pharma Industry Faces New Challenges, Competition, Strategies for Market Dominance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2009)... , VYVANSE is the first stimulant to establish ... after administration in adults with ADHD , , H...hire plc (LSE: SHP, Nasdaq: SHPGY ), the global ...ed results from a Phase 3b study that found VYVANS...d significant efficacy at 14 hours after administr...
(Date:7/1/2009)... , WAYNE, Pa., July 1 ...service multinational contract research organizati...nagement capabilities for clinical trials and pati...maceutical companies, today provided an update to ...announced letter of intent with Pierrel SpA, an in...
(Date:7/1/2009)... , NEW YORK, July 1 N...hat it has raised additional gross funds of over $.... These funds, together with the $11 million priva...nced April 13, 2009, bring the total investment ob...to over $15 million. In addition, affiliates of S...
(Date:7/1/2009)... , ROCKVILLE, Maryland, July 1 /PRNewswire-USNe...HGSI ) today announced that it expects to have top...LISS-52, the first of two pivotal Phase 3 clinical...oStat-B(R)) in systemic lupus erythematosus (SLE)..../prnh/20080416/HGSLOGO ) , , Senior manageme...
Breaking Biology Technology:Study Showed VYVANSE(R) (lisdexamfetamine dimesylate) CII Provided Significant Efficacy at 14 Hours After Administration in Adults with ADHD in an Adult Simulated Workplace Environment 2Study Showed VYVANSE(R) (lisdexamfetamine dimesylate) CII Provided Significant Efficacy at 14 Hours After Administration in Adults with ADHD in an Adult Simulated Workplace Environment 3Study Showed VYVANSE(R) (lisdexamfetamine dimesylate) CII Provided Significant Efficacy at 14 Hours After Administration in Adults with ADHD in an Adult Simulated Workplace Environment 4Study Showed VYVANSE(R) (lisdexamfetamine dimesylate) CII Provided Significant Efficacy at 14 Hours After Administration in Adults with ADHD in an Adult Simulated Workplace Environment 5Study Showed VYVANSE(R) (lisdexamfetamine dimesylate) CII Provided Significant Efficacy at 14 Hours After Administration in Adults with ADHD in an Adult Simulated Workplace Environment 6Study Showed VYVANSE(R) (lisdexamfetamine dimesylate) CII Provided Significant Efficacy at 14 Hours After Administration in Adults with ADHD in an Adult Simulated Workplace Environment 7Study Showed VYVANSE(R) (lisdexamfetamine dimesylate) CII Provided Significant Efficacy at 14 Hours After Administration in Adults with ADHD in an Adult Simulated Workplace Environment 8Encorium Group Updates Expected Timeframe with Respect to the Sale of its U.S. Business 2Encorium Group Updates Expected Timeframe with Respect to the Sale of its U.S. Business 3Encorium Group Updates Expected Timeframe with Respect to the Sale of its U.S. Business 4NeoStem Raises Additional Funds from Principals of Suzhou Erye Pharmaceuticals Company Ltd. and U.S. Institutional and Private Investors, Bringing the Total Recent Financings to Over $15 Million; Funds Will Support Expansion Activities in the United State 2NeoStem Raises Additional Funds from Principals of Suzhou Erye Pharmaceuticals Company Ltd. and U.S. Institutional and Private Investors, Bringing the Total Recent Financings to Over $15 Million; Funds Will Support Expansion Activities in the United State 3Human Genome Sciences to Host July 20 Conference Call to Discuss Top-Line Phase 3 Results for Benlysta(TM) (Formerly Lymphostat-B(R)) in Systemic Lupus Erythematosus 2
...you go? No, I,m not setting up a limbo line for th... how much low tech is required to get high tech of...paying attention to this was the latest spat of id...the archetypal Dorito-munching, Dew-swilling hacke...ts unknown. In one case a bank gave its customer l...
... The next alternative fuel source for Wisconsin ...ement of a restaurant. , ,The Wisconsin Departmen... technological feasibility grant will be awarded t...m to develop cars operating on vegetable oil. Madi...ant chain Culver,s , which has successfully modif...
...atest of irregular alarums and excursions relevant... , How Do You Spell Success? ,Last week, the Midw...d about 30 early stage companies. About 10 were sp...um. , ,Though about 60 individual professional inv...unt estimated that half were no-shows and some big...
...CT image of the carotid arteries that supply blood...icians at University of Michigan Health System are... the extent of brain damage. Graphic: Business Wir...s line of medical imaging systems that give physic...ssels. , ,In Paris on Tuesday, the company showed ...
Other Biology Technology:How low (tech) must you go? 2How low (tech) must you go? 3Environmental group works to run cars on Culver's old frying oil 2Environmental group works to run cars on Culver's old frying oil 3Midwest Venture Summit disappoints; Cato grades Midwest governors 2Midwest Venture Summit disappoints; Cato grades Midwest governors 3Midwest Venture Summit disappoints; Cato grades Midwest governors 4GE Healthcare launches new medical scanner, places another in hospitals 2GE Healthcare launches new medical scanner, places another in hospitals 3
(Date:7/2/2009)..., Bremerhaven, July 2nd 2009. A new measurement ... first time on board of the research vessel Polars... one hand, they spend the greater part of their li...rt of their body can be seen when they surface, an...urrounding water. Visual sightings by marine mamma...
(Date:7/2/2009)... Scientists are to study a group of proteins that...h could hold the key to developing new types of an...f York and Leeds have been awarded 3.3m from the B...cil (BBSRC) to find out how a family of proteins k...lls before destroying them. , The team, led by P...
(Date:7/2/2009)... Scientists have performed the first DNA-based re...prehistoric feathers recovered from caves and rock... University of Adelaide and Landcare Research in N...ies after retrieving ancient DNA from moa feathers...iant birds measuring up to 2.5 metres and weighin...
(Date:7/1/2009)... , Previously, only a few genes had been associat...cancer. Now, researchers of the Max Delbrck Center...it University Medicine Berlin, Germany, have iden... primary tumor and in its metastases. In the futur...aggressive tumors at an earlier stage ( Gastroente...
Breaking Biology News(10 mins):All in sight 2Scientists 'rebuild' giant moa using ancient DNA 2Colorectal cancer 2MedImmune Advances Pediatric Disease Prevention Program With Start of Phase 1 2a Clinical Trial for Respiratory Syncytial Virus Vaccine 3385 1MedImmune Advances Pediatric Disease Prevention Program With Start of Phase 1 2a Clinical Trial for Respiratory Syncytial Virus Vaccine 3385 2Smokers see decline in ability to smell rise in laryngitis and upper airway issues 28575 1Smokers see decline in ability to smell rise in laryngitis and upper airway issues 28575 2Tufts Nelson a leader on Physical Activity Guidelines advisory committee 28573 1Tufts Nelson a leader on Physical Activity Guidelines advisory committee 28573 2Springer launches Cognitive Computation 28571 1Springer launches Cognitive Computation 28571 2
...RYMV) was first identified in 1966 in Kenya. It ha...ere rice is grown. The disease is characterized by...on the leaves. The fertility and development of se...losses at harvest. , Transmission of RYMV occurs ...tact between plants. Prevention measures, like dir...
...living longer, healthier lives since the developme...RT) in 1995. In fact, most patients on the drug re...heir immune cells appear to return to pre-HIV leve...y and the Aaron Diamond AIDS Research Center (ADAR...s may never rebound, suggesting the need for addit...
...me of Ghengis Khan could form the basis of the nex...own source of biologically active chemicals and is...lth drinks and various cosmetics. Juice extracted ...ntists in India have developed a highly efficient ...ol-lowering compounds. Two companies have shown in...
...opulation of pied babblers (Turdoides bicolor) in ... surprising new way in which parent birds can exte...ings are reported by Andrew Radford of the Univers...ty of Cape Town and appear in the September 5th is... , It is well known that birds feed their young di...
Other Biology News:Discovery of the first resistance gene to rice yellow mottle virus 2Discovery of the first resistance gene to rice yellow mottle virus 3HIV-1 kills immune cells in the gut that may never bounce back 2HIV-1 kills immune cells in the gut that may never bounce back 3
Streptomycin sulfate an aminoglycoside used for bacterial selection binds to the small ribosomal subunit and interferes with protein biosynthesis.21H39N7O12)2x3H2SO4Formula weight:
GIBCO Dulbeccos Modified Eagle Medium (D-MEM) (1X); powder (low glucose) from Invitrogen
Adducin beta (C-16)
The BD OptEIA Rat TNF-alpha ELISA Kit is for the quantitative determination of TNF-alpha in rat serum, plasma and cell culture supernatant.
Biology Products: